Zevra Therapeutics (ZVRA) Tax Rate (2014 - 2026)
Zevra Therapeutics' (ZVRA) quarterly Tax Rate came in at 15.43% in Q1 2026, up 7709.0% YoY from 0.2% in Q1 2025, and up 290.13% on a QoQ basis from 3.96% in Q4 2025.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Tax Rate (2014 - 2026) Analysis & Trends
Zevra Therapeutics (ZVRA) has 13 years of Tax Rate data on file, last reported at 15.43% in Q1 2026.
- Quarterly Tax Rate rose 7709.0% year-over-year to 15.43% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6.88% (up 2894.0% YoY) and the FY2025 annual result came in at 3.98%, up 2103.0% from the prior year.
- Tax Rate improved to 15.43% in Q1 2026, from 3.96% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 44.32% in Q3 2025 to a low of 75.47% in Q4 2024.
- A 5-year average of 4.84% and a median of 0.6% in 2024 frame the typical range for Tax Rate.
- The widest YoY moves for Tax Rate: up 7942 bps in 2025, down 6208 bps in 2025.
- Tracing ZVRA's Tax Rate over 5 years: stood at 1.13% in 2022, then slumped by 254 bps to 1.74% in 2023, then tumbled by 4245 bps to 75.47% in 2024, then surged by 105 bps to 3.96% in 2025, then soared by 290 bps to 15.43% in 2026.
- The last three Tax Rate figures came in at 15.43% (Q1 2026), 3.96% (Q4 2025), and 44.32% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Zevra Therapeutics | 734.60 Mn | 513.03 Mn | 38.18 Mn | 31.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.59% |
| Mar 31, 2026 | 15.43% |
| Dec 31, 2025 | 3.96% |
| Sep 30, 2025 | 44.32% |
| Jun 30, 2025 | 2.86% |
| Mar 31, 2025 | -61.66% |
| Dec 31, 2024 | -75.47% |
| Jun 30, 2024 | -0.35% |
| Mar 31, 2024 | 0.42% |
| Sep 30, 2023 | -1.74% |
| Jun 30, 2023 | 2.80% |
| Mar 31, 2023 | 0.77% |
| Dec 31, 2022 | 11.11% |
| Sep 30, 2022 | 0.50% |
| Jun 30, 2022 | 2.89% |
| Mar 31, 2022 | 0.21% |
| Dec 31, 2021 | -1.27% |
| Sep 30, 2020 | 1.12% |
| Dec 31, 2019 | 0.13% |
| Sep 30, 2019 | 0.10% |